scholarly journals Update on syndromes and clinical problems associated with porcine circovirus type 2 infection

2017 ◽  
Vol 56 (3) ◽  
pp. 256
Author(s):  
E. D. TZIKA (Ε. Δ. ΤΖΗΚΑ)

The porcine circoviruses (PCV) are members of the genus Circovirus, family Circoviridae. Two types of PCV have been characterized and were named Porcine Circovirus type 1/PCVl and Porcine Circovirus type 2/PCV2. PCV1 is considered to be avirulent, since it has never been associated with the occurrence of swine disease. On the contrary, PCV2 is identified as virulent porcine pathogen and the virus is considered to have a potential pathogenic role to Post Weaning Multisystemic Wasting Syndrome (PMWS), Porcine Dermatitis and Nephropathy Syndrome (PDNS) and other porcine diseases, although the pathogenesis of this emerging viral infection has not been yet determined. The association of PCV2 and PMWS is now well established. However, it is believed that co-infection with the Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) is necessary for the clinical expression of the syndrome, while Mycoplasma hyopneumoniae, a common finding in PMWS cases, increases the incidence and the severity of PMWS in pigs. The results of experimental trials indicate that PCV2 may need co-factors and/or a long period of incubation to fully reproduce PMWS, while the stimulation of the immune system after vaccination might be a pivotal event in the production of PMWS. The diagnosis is based on clinical signs, necropsy, on the presence of the characteristic histopathological lesions in lymphoid tissues and the presence of PCV2 (antigens, nucleic acid) within the lesions. PDNS has been reported in several pig-producing countries and is characterized by the presence of hemorrhagic skin lesions, oedema of the limbs, necrotizing vasculitis and glomerulonephritis, affecting pigs of 1.4-4 months old. The demonstration of PCV2 antigens and nucleic acid, closely associated with skin and renal lesions, has led to the speculation that PCV2 is an aetiologic agent of this syndrome. Although PCV2 has been consistendy detected in PDNS, lesions consistent with this syndrome have yet to be reproduced experimentally. It is likely that many factors, such as overcrowding, poor ventilation, commingling of different agegroups, co-infection of viruses and bacteria, and other stressors, may act in a synergistic fashion to trigger as yet unidentified mechanisms to induce PDNS. Porcine Respiratory Disease Complex (PRDC) is a serious health problem in growing and finishing pigs aged around 16-22 weeks. Pneumonia in pigs with PRDC is due to a combination of both viral and bacterial agents, such as PRRSV,swine influenza virus, Mycoplasma hyopneumoniae, Actinobacillus pleuropneumoniae and Pasteurella multocida. Some authors suggest that PCV2 could be an important contributor to PRDC, probably by interaction or synergism with other respiratory pathogens, such as PRRSV. PCV2-associated PRDC should be differentiated from PMWS clinically and histopathologically. There have been several experimental and field reports of PCV2-associated reproductive failure (elevated abortion, stillbirths and fetal mummification). Furthermore, it is suggested that porcine proliferative and necrotising pneumonia is a result of a PRRSV and PCV2 coinfection. Moreover, it has been demonstrated that PCV2 and porcine parvovirus may act as cofactors in the experimental reproduction of exudative epidermitis caused by Staphylococcus hyicus. Thus, it is likely that these viruses are involved in lesion development and/or progression of the disease. Respectively, the results of a recent survey indicate that both viruses are highly prevalent in pigs with exudative epidermitis. Additionally, PCV2 is associated with granulomatous enteritis, congenital tremor and lately with necrotizing lemphadenitis, which might be also manifestations of PCV2 infection. It has recendy been hypothesized that different types of PCV2 may be responsible for different disease manifestations. Most of the relevant studies have found minor differences in the respective PCV2 genomes, but at this time remains unclear what significance these minor differences may have. It has been suggested that they may account for different in tropism with respect to the host organism. In addition, other host factors, such as age or route of infection, may affect the pathogenicity and clinical manifestation of PCV2 infection. However, the pathogenical role of PCV2 remains unclear and further studies are therefore needed to define it. The presence of PDNS, PMWS and for the first time the occurrence of PMWS after vaccination against enzootic pneumonia, and the relationship between PMWS-PRRS and PMWS-PRDC as well, have already been described and diagnosed in Greece. Additionally, the genetic analysis of the first PCV2 isolates from pigs presenting various clinical conditions in Greece has been performed.

Viruses ◽  
2019 ◽  
Vol 11 (9) ◽  
pp. 813 ◽  
Author(s):  
Wei ◽  
Van Renne ◽  
Nauwynck

Porcine circovirus type 2 (PCV2) is the etiological agent of PCV2-associated diseases (PCVAD). PCV2 targets lymphoblasts, and pigs suffering from PCVAD display lymphocyte depletion in lymphoid tissues. PCV2 infection of lymphoblasts has not been studied. Here, the replication cycle of PCV2 (abortion strain 1121 and PMWS strain Stoon1010) in T-lymphoblasts was examined. The expression of Rep and Cap were found for both viral strains, while progeny virus was detected for Stoon1010 but not for 1121. PCV2 attached to 11–26% (1121-Stoon1010) of the T-lymphoblasts while 2.6–12.7% of cells showed virus internalization. Chondroitin sulfate (CS) was present on 25% of T-lymphoblasts, and colocalized with PCV2 on 31–32% of the PCV2+ cells. Enzymatic removal of CS reduced PCV2 infection. PCV2 infection was decreased by chlorpromazine, cytochalasin D and Clostridium difficile toxin B for both viral strains and by amiloride for 1121 but not for Stoon1010. Inhibiting either endosome acidification or serine proteases strongly reduced PCV2 infection. Three-dimensional analysis of Cap structure demonstrated a better Cap-nucleic acid affinity for Stoon1010 than for 1121. Taken together, PCV2 binds to T-lymphoblasts partially via CS, enters via clathrin-mediated endocytosis, and disassembles under functions of a pH-drop and serine proteases. Strain Stoon1010 displayed an enhanced viral binding, a specific receptor-mediated endocytosis, an increased Cap-nucleic acid affinity, and a more productive infection in T-lymphoblasts than 1121 did, indicating an evolution from 1121 to Stoon1010.


2019 ◽  
Vol 26 (10) ◽  
pp. 776-784
Author(s):  
Rui Yang ◽  
Yu Tao ◽  
Gaojian Li ◽  
Jian Chen ◽  
Jianhong Shu ◽  
...  

Background:Porcine circovirus and Mycoplasma hyopneumoniae can cause respiratory diseases in pigs, which cause serious economic loss in the worldwide pig industry. Currently, these infections are mainly prevented and controlled by vaccination. The new vaccines on the market are mainly composed of subunits and inactivated vaccines but usually have lower antigenicity than traditional live vaccines. Thus, there is an increasing need to develop new adjuvants that can cause rapid and long-lasting immunity to enhance the antigenic efficacy for vaccines. Studies have shown that meningococcal porin PorB can act as a ligand to combine with Toll-like receptors to activate the production of immunological projections and act as a vaccine immunological adjuvant.Objective:In this article, we expressed and purified the recombinant PorB protein and verified its immunogenicity against porcine circovirus type 2 and Mycoplasma hyopneumoniae genetically engineered vaccine.Methods:In this article, we used prokaryotic expression to express and purify recombinant PorB protein, four different concentrations of PorB protein, Freund's adjuvant with two genetically engineered vaccines were combined with subcutaneous immunization of mice.Results:Our study shows that the appropriate dose of the recombinant protein PorB can enhance the levels of humoral and cellular responses induced by two genetically engineered vaccines in a short period of time in mice. The PorB adjuvant group may cause statistically higher antibody titers for both genetically engineered vaccines compared to Freund's commercial adjuvant (P<0.001).Conclusion:The recombinant protein PorB may be a good candidate adjuvant for improving the protective effect of vaccines against porcine circovirus type 2 and Mycoplasma hyopneumoniae, and the protein can be used for future practical applications.


Viruses ◽  
2019 ◽  
Vol 11 (12) ◽  
pp. 1141
Author(s):  
Xingchen Wu ◽  
Xiaoya Wang ◽  
Tengfei Shi ◽  
Le Luo ◽  
Dan Qiao ◽  
...  

Porcine circovirus type 2 (PCV2) is one of the major threats to pig farms worldwide. Although PCV2 has been identified to promote IL-10 production, the detailed regulatory roles of PCV2 Rep for IL-10 production remain unclear. Herein, we first found that PCV2 Rep, rather than PCV1 Rep, enhanced IL-10 expression at the later phase of PCV2 infection in porcine alveolar macrophages (PAMs). Furthermore, we found that PCV2 Rep directly activated the p38-MAPK pathway to promote transcription factors NF-κB p50 and Sp1 binding to the il10 promoter, but PCV1 Rep did not. During PCV2 infection, however, PCV2 Rep promoted the binding activities of NF-κB p50 and Sp1 with the il10 promoter only at the later phase of PCV2 infection, since Rep proteins only expressed at the later phase of the infection. Moreover, silence of the thymine DNA glycosylase (TDG), a Rep-binding protein, significantly reduced the binding activities of NF-κB p50 and Sp1 with il10 promoter, resulting in the reduction of IL-10 production in PCV2-inoculated PAMs at the later phase of infection. Taken together, our results demonstrate that Rep proteins enhance IL-10 production during PCV2 infection of PAMs via activation of p38-MAPK pathways, in which host TDG is a critical mediator.


2015 ◽  
Vol 1 (1) ◽  
Author(s):  
Eleni D. Tzika ◽  
Panagiotis D. Tassis ◽  
Dimitrios Koulialis ◽  
Vassileios G. Papatsiros ◽  
Tom Nell ◽  
...  

2021 ◽  
Author(s):  
Daniela Jiménez-Arriagada ◽  
Alejandro A. Hidalgo ◽  
Victor Neira ◽  
Andrónico Neira-Carrillo ◽  
Sergio A. Bucarey

Abstract Background Porcine circovirus type 2 (PCV2)-associated diseases are a major problem for the swine industry worldwide. In addition to vaccines, the availability of antiviral polymers provides an efficient and safe option for reducing the impact of these diseases. By virtue of their molecular weight and repetitious structure, polymers possess properties not found in small-molecule drugs. In this perspective, we focus on chitosan, a ubiquitous biopolymer, that adjusts the molecular weight and sulfated-mediated functionality could act as a efficient antiviral polymer by mimicking PCV2-cell receptor interactions. Methods Sulfated chitosan (Chi-S) polymers of two molecular weights were synthesized and characterized by FTIR, SEM-EDS and elemental analysis. The Chi-S solutions were tested against PCV2 infection in PK15 cells in vitro and antiviral activity was evaluated by measuring the PCV2 copy number upon application different molecular weights, sulfate functionalization, and concentration of polymer. In addition, to explore the mode of action of the Chi-S against PCV2 infection, experiments were designed to clarify whether the antiviral activity of the Chi-S would be influenced by when it was added to the cells, relative to the time and stage of viral infection. Results Chi-S significantly reduced genomic copies of PCV2, showing specific antiviral effects depending on its molecular weight, concentration, and chemical functionalization. Assays designed to explore the mode of action of Chi-S revealed that exerted antiviral activity through impeding viral attachment and penetration into cells. Conclusions These findings help better understanding PCV2-porcine cells interaction and reinforce the idea that sulfated polymers, such as Chi-S, represent a promising candidate for uses in antiviral therapies against PCV2-associated diseases.


Sign in / Sign up

Export Citation Format

Share Document